Rhumbline Advisers »

Bicara Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Bicara Therapeutics

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.001331.112k331.1125k331.113k331.1135k331.114k19.007k19.0075k19.008k19.0085k19.009k
Value ($)Share countHistorical BCAX position of Rhumbline Advisers Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $331k 19k 17.42

More positions owned by Rhumbline Advisers

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Berkshire Hathaway (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa (V)
MasterCard Incorporated (MA)
Exxon Mobil Corporation (XOM)

View all positions for Rhumbline Advisers

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Omega Fund Management
Adage Capital Partners GP
FMR
Braidwell
Deerfield Management Company
T. Rowe Price Associates
Fairmount Funds Management
BlackRock
Vanguard Group
Fil
Blackstone Group
Henderson Group

View all funds holding Bicara Therapeutics